SCHEMBL17907978

SCHEMBL17907978

O=C(O)/C=C/c1cc2cc(F)ccc2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.55
PDPK1 O15530 1/20 0.55
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
HPGD P15428 1/20 0.55
TSHR P16473 1/20 0.55
NFKB1 P19838 1/20 0.55
APEX1 P27695 1/20 0.55
CYP2C19 P33261 1/20 0.55
HSD17B10 Q99714 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
TDO2 P48775 1/20 0.49
DAO P14920 1/20 0.47
FLT3 P36888 6/20 0.47
ATM Q13315 1/20 0.44
KCNA6 P17658 1/20 0.42
KCNA3 P22001 1/20 0.42
KCNA4 P22459 1/20 0.42
MLLT1 Q03111 1/20 0.41
HRH4 Q9H3N8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17907980 1.00 KDM4E (0.55) KDM4EPDPK1ALDH1A1LMNAHPGD
SCHEMBL15466232 0.88 TDO2 (0.52) KDM4EPDPK1ALDH1A1LMNAHPGD
SCHEMBL15466233 0.88 TDO2 (0.52) KDM4EPDPK1ALDH1A1LMNAHPGD
SCHEMBL17907958 0.81 PIN1 (0.55) KDM4EALDH1A1HPGDHSD17B10DAO
SCHEMBL17908002 0.81 F7 (0.55) KDM4EALDH1A1LMNADAOFLT3
SCHEMBL17908005 0.81 F7 (0.55) KDM4EALDH1A1LMNADAOFLT3
SCHEMBL17907955 0.81 PIN1 (0.55) KDM4EALDH1A1HPGDHSD17B10DAO
SCHEMBL5829214 0.79 PDGFRB (0.57) KDM4EALDH1A1LMNAHPGDTSHR
SCHEMBL5829213 0.79 PDGFRB (0.57) KDM4EALDH1A1LMNAHPGDTSHR
SCHEMBL245110 0.79 CYP2A6 (0.58) KDM4EHPGDCYP2C19HSD17B10DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2697223-B1 7-(HETEROARYL-AMINO)-6,7,8,9-TETRAHYDROPYRIDO[1,2-A]INDOL ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2016-07-13 EP disclosed